{"id":"https://openalex.org/W4306648667","doi":"https://doi.org/10.1111/1756-185x.14462","title":"Lower injection\u2010site reactions and long\u2010term safety, immunogenicity, and efficacy of etanercept biosimilar YLB113 : Results from a post\u2010hoc analysis of a double\u2010blind, randomized, phase III comparative study and its open\u2010label extension in patients with rheumatoid arthritis","display_name":"Lower injection\u2010site reactions and long\u2010term safety, immunogenicity, and efficacy of etanercept biosimilar YLB113 : Results from a post\u2010hoc analysis of a double\u2010blind, randomized, phase III comparative study and its open\u2010label extension in patients with rheumatoid arthritis","publication_year":2022,"publication_date":"2022-10-17","ids":{"openalex":"https://openalex.org/W4306648667","doi":"https://doi.org/10.1111/1756-185x.14462","pmid":"https://pubmed.ncbi.nlm.nih.gov/36253032","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10092464"},"language":"en","primary_location":{"id":"doi:10.1111/1756-185x.14462","doi":"https://doi.org/10.1111/1756-185x.14462","is_oa":true,"landing_page_url":"https://doi.org/10.1111/1756-185x.14462","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1756-185X.14462","source":{"id":"https://openalex.org/S169069398","display_name":"International Journal of Rheumatic Diseases","issn_l":"1756-1841","issn":["1756-1841","1756-185X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Rheumatic Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1756-185X.14462","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063192431","display_name":"Hisashi Yamanaka","orcid":"https://orcid.org/0000-0001-8453-6731","observed_orcids":["https://orcid.org/0000-0001-8453-6731"]},"institutions":[{"id":"https://openalex.org/I4210136522","display_name":"Tokyo Women's Medical University","ror":"https://ror.org/03kjjhe36","country_code":"JP","type":"education","lineage":["https://openalex.org/I4210136522"]},{"id":"https://openalex.org/I4210162813","display_name":"Sanno Medical Center","ror":"https://ror.org/055mpn097","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210162813"]},{"id":"https://openalex.org/I79072001","display_name":"International University of Health and Welfare","ror":"https://ror.org/053d3tv41","country_code":"JP","type":"education","lineage":["https://openalex.org/I79072001"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hisashi Yamanaka","raw_affiliation_strings":["International University of Health and Welfare, Tokyo, Japan","Sanno Medical Center, Tokyo, Japan","Women's Medical University School of Medicine, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International University of Health and Welfare, Tokyo, Japan","institution_ids":["https://openalex.org/I79072001"]},{"raw_affiliation_string":"Sanno Medical Center, Tokyo, Japan","institution_ids":["https://openalex.org/I4210162813"]},{"raw_affiliation_string":"Women's Medical University School of Medicine, Tokyo, Japan","institution_ids":["https://openalex.org/I4210136522"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015953107","display_name":"Yoshiya Tanaka","orcid":"https://orcid.org/0000-0002-0807-7139","observed_orcids":["https://orcid.org/0000-0002-0807-7139"]},"institutions":[{"id":"https://openalex.org/I188700360","display_name":"University of Occupational and Environmental Health Japan","ror":"https://ror.org/020p3h829","country_code":"JP","type":"education","lineage":["https://openalex.org/I188700360"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshiya Tanaka","raw_affiliation_strings":["University of Occupational and Environmental Health, Kitakyushu, Japan"],"raw_orcid":"https://orcid.org/0000-0002-0807-7139","affiliations":[{"raw_affiliation_string":"University of Occupational and Environmental Health, Kitakyushu, Japan","institution_ids":["https://openalex.org/I188700360"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Toshihiko Hibino","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toshihiko Hibino","raw_affiliation_strings":["YL Biologics Ltd., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"YL Biologics Ltd., Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001771713","display_name":"Unmesh Gopalakrishnan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387153459","display_name":"Viatris","ror":"https://ror.org/01g1gvr46","country_code":"US","type":"company","lineage":["https://openalex.org/I4387153459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gopalakrishnan Unmesh","raw_affiliation_strings":["Viatris, Bengaluru, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Viatris, Bengaluru, India","institution_ids":["https://openalex.org/I4387153459"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Chirag Shah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I21675474","display_name":"Lupin Pharmaceuticals (India)","ror":"https://ror.org/04wdr7416","country_code":"IN","type":"company","lineage":["https://openalex.org/I21675474"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Chirag Shah","raw_affiliation_strings":["Lupin LTD, Pune, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lupin LTD, Pune, India","institution_ids":["https://openalex.org/I21675474"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027031788","display_name":"Dhananjay Bakhle","orcid":"https://orcid.org/0000-0001-8701-9561","observed_orcids":["https://orcid.org/0000-0001-8701-9561"]},"institutions":[{"id":"https://openalex.org/I21675474","display_name":"Lupin Pharmaceuticals (India)","ror":"https://ror.org/04wdr7416","country_code":"IN","type":"company","lineage":["https://openalex.org/I21675474"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Dhananjay Bakhle","raw_affiliation_strings":["Lupin LTD, Pune, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lupin LTD, Pune, India","institution_ids":["https://openalex.org/I21675474"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067462672","display_name":"Dimitris Stefanidis","orcid":"https://orcid.org/0000-0001-9018-981X","observed_orcids":["https://orcid.org/0000-0001-9018-981X"]},"institutions":[{"id":"https://openalex.org/I4210145546","display_name":"Baxter (Germany)","ror":"https://ror.org/05jgtkc28","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210145546","https://openalex.org/I99484792"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Dimitris Stefanidis","raw_affiliation_strings":["Viatris GmbH  Bad Homburg vor der H\u00f6he Germany"],"raw_orcid":"https://orcid.org/0000-0001-9018-981X","affiliations":[{"raw_affiliation_string":"Viatris GmbH  Bad Homburg vor der H\u00f6he Germany","institution_ids":["https://openalex.org/I4210145546"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5067462672"],"corresponding_institution_ids":["https://openalex.org/I4210145546"],"apc_list":{"value":3250,"currency":"USD","value_usd":3250},"apc_paid":{"value":3250,"currency":"USD","value_usd":3250},"fwci":0.5615,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.54486325,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"26","issue":"1","first_page":"108","last_page":"115"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/etanercept","display_name":"etanercept","score":0.8289999961853027},{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":0.9700000286102295},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9950000047683716},{"id":"https://openalex.org/keywords/injection-site-reactions","display_name":"injection site reactions","score":0.9909999966621399},{"id":"https://openalex.org/keywords/injection-site-erythema","display_name":"injection site erythema","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anti-drug-antibodies","display_name":"anti-drug antibodies","score":0.8519999980926514},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.9120000004768372},{"id":"https://openalex.org/keywords/efficacy","display_name":"efficacy","score":0.5649999976158142},{"id":"https://openalex.org/keywords/das28","display_name":"DAS28","score":0.9340000152587891},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.6579999923706055}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.916885495185852},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.7557654976844788},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6690813302993774},{"id":"https://openalex.org/C2777226972","wikidata":"https://www.wikidata.org/wiki/Q415343","display_name":"Etanercept","level":3,"score":0.5798618793487549},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5714852213859558},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5575552582740784},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5537487268447876},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.5275910496711731},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.4914129972457886},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.47728386521339417},{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.4627736806869507},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4189014434814453},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.32316523790359497},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.18751657009124756},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.17731842398643494},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000068800","descriptor_name":"Etanercept","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000075662","descriptor_name":"Injection Site Reaction","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D000075662","descriptor_name":"Injection Site Reaction","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D000075662","descriptor_name":"Injection Site Reaction","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/1756-185x.14462","doi":"https://doi.org/10.1111/1756-185x.14462","is_oa":true,"landing_page_url":"https://doi.org/10.1111/1756-185x.14462","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1756-185X.14462","source":{"id":"https://openalex.org/S169069398","display_name":"International Journal of Rheumatic Diseases","issn_l":"1756-1841","issn":["1756-1841","1756-185X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Rheumatic Diseases","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10092464","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10092464","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10092464/pdf/APL-26-108.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int J Rheum Dis","raw_type":"Text"},{"id":"pmid:36253032","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36253032","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of rheumatic diseases","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":{"id":"doi:10.1111/1756-185x.14462","doi":"https://doi.org/10.1111/1756-185x.14462","is_oa":true,"landing_page_url":"https://doi.org/10.1111/1756-185x.14462","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1756-185X.14462","source":{"id":"https://openalex.org/S169069398","display_name":"International Journal of Rheumatic Diseases","issn_l":"1756-1841","issn":["1756-1841","1756-185X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Rheumatic Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4306648667.pdf","grobid_xml":"https://content.openalex.org/works/W4306648667.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W2008138329","https://openalex.org/W2035642138","https://openalex.org/W2071095038","https://openalex.org/W2159106700","https://openalex.org/W2293590090","https://openalex.org/W2624289061","https://openalex.org/W2626689945","https://openalex.org/W2759349664","https://openalex.org/W2890017737","https://openalex.org/W2996682695","https://openalex.org/W3010713619","https://openalex.org/W3199684820","https://openalex.org/W4308769923"],"related_works":["https://openalex.org/W3164186675","https://openalex.org/W3164218895","https://openalex.org/W2996682695","https://openalex.org/W2953033542","https://openalex.org/W2780872292","https://openalex.org/W2947562759","https://openalex.org/W3010713619","https://openalex.org/W6940065202","https://openalex.org/W2764032337","https://openalex.org/W3112964157"],"abstract_inverted_index":{"AIM:":[0],"YLB113":[1,65,199,227,241],"biosimilar":[2],"was":[3,91,132,171],"evaluated":[4],"in":[5,18,95,248],"an":[6,139],"open-label":[7,145],"extension":[8,146],"single-arm":[9],"study":[10,56,161,177,256],"to":[11,130,236],"assess":[12],"long-term":[13,229],"safety,":[14],"efficacy,":[15],"and":[16,36,82,119,152,185,213,231,246],"immunogenicity":[17],"patients":[19],"with":[20,221,259],"rheumatoid":[21],"arthritis":[22],"(RA).":[23],"We":[24],"also":[25],"report":[26],"post-hoc":[27,197,250],"results":[28],"on":[29,240],"the":[30,48,59,111,144,176,190,193,196,222,253],"incidence":[31,140,205],"of":[32,124,136,141,192,206,252],"injection-site":[33,37],"reactions":[34],"(ISRs)":[35],"erythema":[38],"(ISE)":[39],"from":[40,47,93],"a":[41,201,249],"phase":[42,49,254],"III":[43,255],"study.":[44,112,147,194],"METHOD:":[45],"Participants":[46],"III,":[50],"double-blind,":[51],"randomized,":[52],"96":[53,237],"week":[54,183],"equivalence":[55],"who":[57],"completed":[58,110],"final":[60],"visit":[61],"received":[62],"50":[63],"mg":[64],"subcutaneously":[66],"every":[67],"2":[68],"weeks.":[69,238],"Key":[70],"safety":[71,230],"end":[72,89,191],"points":[73],"were":[74,115],"assessed":[75],"through":[76],"adverse":[77],"events":[78],"(AEs),":[79],"ISRs,":[80],"ISE,":[81],"anti-drug":[83],"antibody":[84],"(ADA)":[85],"incidence.":[86],"The":[87,126,164],"efficacy":[88,233],"point":[90],"change":[92,170],"baseline":[94],"Disease":[96],"Activity":[97],"Score":[98],"28-joint":[99],"count":[100],"(DAS28)":[101],"over":[102],"time.":[103],"RESULTS:":[104],"Of":[105],"201":[106],"participants,":[107],"184":[108],"(91.5%)":[109],"Treatment-emergent":[113],"AEs":[114,121,131],"experienced":[116,242],"by":[117,122],"93.5%":[118],"severe":[120],"10.0%":[123],"participants.":[125],"discontinuation":[127],"rate":[128],"due":[129],"2.0%.":[133],"Overall,":[134],"20.0%":[135],"participants":[137,149],"reported":[138],"ISRs":[142,207,245],"throughout":[143],"Two":[148],"developed":[150,154],"ADAs,":[151],"none":[153],"neutralizing":[155],"ADAs":[156],"at":[157,175,182,189],"any":[158],"time":[159],"after":[160],"drug":[162],"administration.":[163],"overall":[165],"DAS28":[166],"(mean":[167],"\u00b1":[168,173,180,187],"SD)":[169],"2.22":[172],"0.95":[174],"transition,":[178],"2.10":[179],"0.91":[181],"72,":[184],"2.06":[186],"0.89":[188],"In":[195],"analysis,":[198],"showed":[200],"statistically":[202],"significant":[203],"lower":[204,244],"(10":[208],"[3.8%],":[209],"P":[210,217],"<":[211,218],"0.0001)":[212,219],"ISE":[214,247],"(5":[215],"[1.9%],":[216],"compared":[220,258],"reference":[223,260],"product":[224],"Enbrel\u00ae.":[225],"CONCLUSION:":[226],"demonstrated":[228],"sustained":[232],"for":[234],"up":[235],"Patients":[239],"significantly":[243],"analysis":[251],"when":[257],"product.":[261]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-10-18T00:00:00"}